WHO ICTRP trial
Expression and role of BTLA and HLA-DR in sepsis
ChiCTR2400089633 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400089633 |
|---|---|
| Public title | Expression and role of BTLA and HLA-DR in sepsis |
| Scientific title | Expression and role of BTLA and HLA-DR in sepsis |
| Primary sponsor | Dalian Friendship Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | sepsis |
| Interventions | Sepsis group:NA;Control group:NA |
| Registration date | Sep 12, 2024 |
| Target size | Sepsis group:40;Control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: